XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities    
Net loss $ (1,715,290) $ (5,340,773)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,107 1,669
Equity-based compensation expense 77,508 203,345
Changes in operating assets and liabilities:    
Grants receivable 0 1,480,490
Prepaid expenses and other assets 175,052 280,728
Accounts payable 111,104 627,576
Accrued expenses and other current liabilities (3,436) (422,470)
Net cash used in operating activities (1,353,955) (3,169,435)
Financing activities    
Proceeds from issuance of equity securities, net 38 336,682
Payments on note payable (172,788) 0
Net cash provided by financing activities (172,750) 336,682
Net decrease in cash, cash equivalents and restricted cash (1,526,705) (2,832,753)
Cash, cash equivalents and restricted cash at beginning of period 5,899,910 12,106,435
Cash, cash equivalents and restricted cash at end of period 4,373,205 9,273,682
Non-cash investing and financing activities:    
Cash paid for interest 4,019 0
Common stock issued for in-process research and development technology $ 0 $ 25,000